Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Brinda Dixit (NPI 1275514861)

Field	Value
Entity Type	Individual
Organization	Brinda Dixit
Address	516 Innovation Dr
City	Chesapeake
State	VA
ZIP	23320
Taxonomy	Rheumatology Physician
NPI Enumerated	November 10, 2005

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-focused practice: total Medicare revenue is $2.5M and there is no Medicaid billing on file, so the provider’s book of business is single‑payer in scope and materially dependent on Medicare reimbursement flows. The absence of Medicaid activity suggests limited exposure to state Medicaid contracting but increases sensitivity to Medicare drug administration and office visit reimbursement policies.

Revenue is highly concentrated in a small number of biologic drug administration codes: the top three Medicare codes (J0129, J0717, J1602) account for 71.8% of the provider’s total Medicare revenue, with J0129 at 32.6%, J0717 at 23.2%, and J1602 at 16.0%. This concentration indicates that a few high-cost biologic treatments drive most of practice revenue.

The CPT/HCPCS mix is consistent with a rheumatology practice that operates an in‑office biologics infusion/administration service line: high-revenue drug codes such as J0129 (abatacept), J0717 (certolizumab pegol), J1602 (golimumab), plus additional biologics like J3262 (tocilizumab, $280.6K, 10.8%) and J0897 (denosumab, $203K, 7.8%), point to routine on-site biologic injections/infusions coupled with associated administration billing. Procedural support codes for infusions and injections (e.g., 96365 with $26.7K, 1.0% of revenue, and 96413 with $12.4K, 0.5% of revenue) further reinforce an infusion-capable clinic model.

Competitive standing is mixed across leading drug codes: the provider is a national high-volume administrator of abatacept (J0129 ranks #76 of 1221 providers nationally, 94th percentile; notably above typical national volume), while certolizumab (J0717 ranks #61 of 848, 93th percentile) and golimumab (J1602 ranks #96 of 1041, 91th percentile) volumes are described as typical or unremarkable despite high rank percentiles. In short, the practice is a prominent national administrator for at least one key biologic but otherwise aligns with common national patterns for several other biologics.

Visit intensity and procedural throughput are notable relative to peers: higher‑level evaluation and management codes appear at elevated rates (99214: 762 claims, $67.8K, 2.6% of revenue, ranks #21863 of 479517, 95th percentile; 99215: 447 claims, $62.6K, 2.4% of revenue, ranks #2520 of 145531, 98th percentile and labeled an extreme outlier). High claims for basic injection services are also an outlier (96372: 974 claims, $10.7K, 0.4% of revenue, ranks #412 of 58224, 99th percentile; labeled extreme outlier), which together suggest a practice that manages relatively complex patients and performs a large volume of in-office injections.

On-site diagnostic and procedural capabilities are evident: the provider reports 468 claims for 76881 (joint ultrasound) generating $4.2K (0.2% of Medicare revenue) and ranks #55 of 1606 providers nationally (97th percentile), indicating routine use of ultrasound for joint assessment and procedural guidance. This capability supports both diagnostic evaluation and guided joint procedures, consistent with a rheumatology clinic that combines medical management with procedural services.

Operational and revenue risk considerations stem from the practice’s biologic concentration and Medicare-only footprint: with top biologic codes making up 71.8% of Medicare revenue and no Medicaid revenue recorded, changes in drug reimbursement, buy-and-bill margin pressure, or shifts in Medicare policy could materially affect topline performance. The single-payer concentration also limits diversification benefits and could impact negotiations or referral strategy.

The provider is long-tenured: NPI enumeration date is 2005-11-10 (~21 years ago), which suggests an established clinical presence that may have supported the development of the current infusion and high-intensity office visit patterns over time. Tenure combined with the code mix implies a stable referral base and operational experience in managing biologic therapies and complex rheumatology patients.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	25,000	$30	$850K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	150,800	$1	$603.2K
J1602	Injection, golimumab, 1 mg, for intravenous use	37,900	$10	$416.9K
J3262	Injection, tocilizumab, 1 mg	56,120	$10	$280.6K
J0897	Injection, denosumab, 1 mg	11,280	$20	$203K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	760	$90	$67.8K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	450	$140	$62.6K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	520	$50	$26.7K
99490	The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the…	440	$50	$21.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	120	$110	$12.4K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Brinda Dixit — 6 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	2	30	10,450	$30	$407.3K
J3262	14	20	75,870	$1	$383.3K
J0717	6	30	74,500	$1	$361.7K
J1602	2	20	13,430	$10	$176.7K
J0897	28	340	2,820	$20	$89.3K
96413	169	230	250	$100	$28.5K
99214	878	12,890	140	$80	$21K
99490	114	510	130	$50	$15.5K
96401	145	180	110	$60	$11.5K
99213	7,994	12,440	90	$60	$10K

Showing 1–10 of 24

Nearby Providers

Other providers in the same ZIP code as Brinda Dixit, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Chesapeake Hospital Authority	VA	General Acute Care Hospital	$0	$45.6M
Hnh Virginia, Inc.	VA	Home Health Agency	$0	$42.9M
Gateway Services, LLC	VA	Community/Behavioral Health Agency	$0	$39.8M
Sentara Enterprises	VA	Home Infusion Agency	$0	$38.7M
City Of Chesapeake	VA	Community/Behavioral Health Agency	$0	$27.4M
Clients First Home Health Inc.	VA	Home Health Agency	$0	$24.8M
Immanual Care	VA	Home Health Agency	$0	$23M
Y Christian Care LLC	VA	Home Health Agency	$0	$18.7M
Sentara Enterprises	VA	Home Health Agency	$0	$12.5M
Renaissance Counseling Services, LLC	VA	Community/Behavioral Health Agency	$0	$10.8M

Brinda Dixit — Billing Profile & Reimbursement Data

Sign up for Brinda Dixit — Billing Profile & Reimbursement Data policy alerts

Brinda Dixit — Billing Profile & Reimbursement Data

Sign up for Brinda Dixit — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References